<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A case of Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (stage IV) in an 8-year-old boy with <z:hpo ids='HP_0003774'>end-stage renal failure</z:hpo> due to <z:hpo ids='HP_0005575'>hemolytic uremic syndrome</z:hpo> is reported </plain></SENT>
<SENT sid="1" pm="."><plain>The boy was treated by maintenance hemodialysis (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>) and hemofiltration (HF) </plain></SENT>
<SENT sid="2" pm="."><plain>During chemotherapy treatment with continuous <z:chebi fb="1" ids="16040">cytosine</z:chebi> <z:chebi fb="0" ids="22601">arabinoside</z:chebi> (Ara-C) infusion (100 mg/m2/d) for 7 days, concentrations of Ara-C and its metabolite <z:chebi fb="0" ids="17568">uracil</z:chebi> <z:chebi fb="0" ids="22601">arabinoside</z:chebi> (Ara-U) were measured in blood, dialysate, and filtrate </plain></SENT>
<SENT sid="3" pm="."><plain>Ara-C levels were always below 200 ng/ml and were only qualitatively detectable in blood, dialysate, and filtrate </plain></SENT>
<SENT sid="4" pm="."><plain>Ara-U levels were higher than 200 ng/ml after 18 h treatment and were measured quantitatively </plain></SENT>
<SENT sid="5" pm="."><plain>Ara-U clearance during 3 h <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> was 92 ml/min and the calculated mass removal 14.7 mg/3 h </plain></SENT>
<SENT sid="6" pm="."><plain>In contrast, the Ara-U clearance during 3 h HF was 14 ml/min and the mass removal was 6.7 mg/3 h </plain></SENT>
<SENT sid="7" pm="."><plain>Ara-C and Ara-U are eliminated by <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> and HF in anuric patients </plain></SENT>
<SENT sid="8" pm="."><plain>A continuous infusion of 100 mg Ara-C m2/d during <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> or HF treatment did not result in a serum concentration above 200 ng/ml </plain></SENT>
</text></document>